Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) [Phase 3]
Phase 3 clinical trial update evaluating palifermin for reduction of oral mucositis in patients with hematologic cancers undergoing intensiv…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Evaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell Collection [Phase 2]
A Phase 2 clinical trial evaluating plerixafor in combination with chemotherapy and G-CSF for stem cell collection in patients with multiple…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating autologous stem cell transplantation using Zevalin with BEAM conditioning for lymphoma; results we…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors [Phase 1]
This document provides a Phase 1 clinical trial update on using Interleukin-12 to treat various hematologic cancers and solid tumors; the st…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluated the combination of panobinostat and everolimus in relapsed or refractory lymphoma; results from the completed st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer [Phase 2]
Phase 2 trial evaluating a five-drug combination (etoposide, cyclophosphamide, thalidomide, celecoxib, and fenofibrate) in relapsed or progr…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE [NA]
A clinical trial evaluating REGKINE for T-regulatory cell kinetics in stem cell transplantation was terminated, and results have been posted…
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial results evaluating rituximab after autologous stem cell transplant in relapsed B-cell non-Hodgkin lymphoma have been completed…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Metabolic Syndrome in Childhood Cancer Survivors
This clinical trial update notes the completion of a study on metabolic syndrome in childhood cancer survivors, sponsored by the University …
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET [Phase 3]
Phase 3 trial evaluating whether diphenoxylate/atropine reduces FDG activity during F-18 FDG PET imaging in lymphoma patients; the study has…
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer [Phase 2]
This Phase 2 trial tested sirolimus, tacrolimus, and antithymocyte globulin for preventing graft-versus-host disease in patients undergoing …
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: American Ginseng in Treating Patients With Fatigue Caused by Cancer [Phase 3]
A phase 3 trial evaluating American ginseng for cancer-related fatigue has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients [Phase 2]
Phase 2 trial evaluating pharmacokinetic-directed dosing of IV busulfan as conditioning for autologous stem cell transplantation in lymphoma…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Interferon Alfa in Treating Children With HIV-Related Cancer [Phase 2]
Phase 2 trial evaluating interferon alfa in children with HIV-related cancer (leukemia, lymphoma, and unspecified childhood solid tumors) ha…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients
This clinical trial update reports on hepatitis B reactivation risk in lymphoma patients after withdrawal of prophylactic antiviral therapy,…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Combination Chemotherapy in Treating Children With Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy in children with lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze [Phase 1]
Open-label pharmacokinetic study of leucovorin in patients receiving high-dose methotrexate, with or without Voraxaze, completed Phase 1.
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases [NA]
Clinical trial update on donor stem cell transplantation for hematologic cancers and related diseases completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
The clinical trial evaluating blood stem cell transplants in adults and children with various hematologic cancers, sponsored by Columbia Uni…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath [Phase 2]
Phase 2 update on non-myeloablative allogeneic stem cell transplantation using mis-matched family donor cells purged with Campath (alemtuzum…
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Safety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT [Phase 1]
Phase 1 safety trial of a natural killer donor lymphocyte infusion from a 6/6 HLA-matched family member after nonmyeloablative autologous st…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath [Phase 2]
Phase 2 study of an allogeneic non-myeloablative stem cell transplant using matched family member donor cells purged with Campath (alemtuzum…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants [Phase 1]
Phase 1 trial evaluating total body irradiation with fludarabine followed by combined umbilical cord blood transplants has completed. The tr…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers [Phase 2]
A Phase 2 trial evaluating a conditioning regimen of total-body irradiation with tacrolimus and mycophenolate mofetil followed by bone marro…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial evaluating Interleukin-2 after bone marrow transplantation for hematologic cancers has completed.